ClariMed Advances Growth with Strategic Acquisition of We Are Human

ClariMed Inc., a global leader in human-centered medical device development and regulatory services, has announced its strategic acquisition of We Are Human, a consultancy based in the UK and the US, specializing in user-centered design and research in innovative medical technologies. The acquisition allows ClariMed to expand its geographical footprint into the Southeast with We Are Human's advanced research hub in Atlanta, simultaneously advancing its mission to implement human-centered innovative medical technologies accessible to needed communities. Annmarie Nicolson, founder of We Are Human, joins ClariMed as a director, bringing her extensive experience in early formative research, contextual inquiry, and user experience research for medical technology innovation to the executive team. This acquisition bolsters ClariMed's position as an integrated service partner for medical devices by expanding its specialized expertise in user experience research, regulatory compliance, and design validation across US and UK markets. The Atlanta lab will become ClariMed's new research facility, providing access to diverse study populations in the Southeast while supporting the company's growing client base. ClariMed CEO Kelley Kendle emphasized the acquisition's alignment with their user-centered foundation, regional variability benefits, and commitment to making medical technology safer, intuitive, and efficient. This acquisition aligns with ClariMed's growth strategy to develop comprehensive, human-centered solutions for medical device development, benefitting pharmaceutical and device manufacturers by accelerating market entry while enhancing patient safety and user experience.